Nestle Investing In Mitochondria Research4 years, 2 months ago
Posted on Apr 06, 2019, 5 p.m.
Nestle Health Science is partnering with Amazentis and is taking an equity stake in return for global rights to use the patented Urolithin A technology in foods, beverages, dietary supplements, and medical nutritional products.
Urolithin A technology is currently being evaluated in the second phase of two clinical trials; it is a metabolite naturally produced when consuming foods similar to pomegranates, and is the first natural bioactive to boost function through clearing aging and damaged mitochondria from cells.
Urolithin A has received GRAS designation from the US FDA, meaning it is generally recognized as safe. Although financial details were not released CEO Greg Behar of Nestle Health Science said “...the partnership will include a significant investment to support further research and development..” Co-founder and CEO of Amazentis Chris Rinsch says “...the partnership will enable us to make this breakthrough more widely available and support consumers in the proactive management of their cellular health…”
Nestle Health Science has also invested in other functional foods and beverages designed to fight chronic illness, so this new development should not come as a surprise to any following the world’s largest food company. This investment also makes sense since the marketing potential of nutrients to counteract cell aging is set to explode as large segments of the global population get older; with the oncoming Silver Tsunami those aged 65+ will soon make up the largest single age group in the country and will maintain that status for years according to the US Census.
Nestle Health Science other nutritional applications target inherited metabolic disorders, such as the Vitaflo line of medical food products designed for those with several conditions including phenylketonuria and maple syrup urine disease.
Part of Nestle Health Science mission is to develop scientific methods to improve health through nutrition, the company stands to gain much if they are able to adapt the patented Urolithin A technology into use in foods and beverages.
Use of Urolithin A technology could bolster some food and beverage products with cell building ingredients and accompanying claims, which may appeal to the growing number of graying consumers looking to add functional properties to their diets.
More foods and beverages may be designed to bolster mitochondrial function as information is shared, according to World’s Healthiest Foods maintaining mitochondria’s structural integrity will help make sure the muscles, heart, and brain have enough energy to function properly, without it unhealthy aging and fatigue will result.
Consumers aware of the risks of mitochondrial dysfunction such as diabetes, Parkinson’s disease, and congestive heart failure will very likely be paying close attention for any products launched that help out and support mitochondrial health and function. This is a very smart move by Nestle Health Science, one which we may all benefit from.
Material provided by:
Note: Content may be edited for style and length.